Boston Scientific Long Term Debt 2010-2025 | BSX
Boston Scientific long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Boston Scientific long term debt for the quarter ending March 31, 2025 was $10.532B, a 10.47% increase year-over-year.
- Boston Scientific long term debt for 2024 was $8.968B, a 4.63% increase from 2023.
- Boston Scientific long term debt for 2023 was $8.571B, a 3.86% decline from 2022.
- Boston Scientific long term debt for 2022 was $8.915B, a 1.26% increase from 2021.
| Boston Scientific Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $8,968 |
| 2023 | $8,571 |
| 2022 | $8,915 |
| 2021 | $8,804 |
| 2020 | $9,130 |
| 2019 | $8,592 |
| 2018 | $4,803 |
| 2017 | $3,815 |
| 2016 | $5,420 |
| 2015 | $5,674 |
| 2014 | $3,841 |
| 2013 | $4,237 |
| 2012 | $4,252 |
| 2011 | $4,257 |
| 2010 | $4,934 |
| 2009 | $5,915 |
| Boston Scientific Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-03-31 | $10,532 |
| 2024-12-31 | $8,968 |
| 2024-09-30 | $9,233 |
| 2024-06-30 | $8,991 |
| 2024-03-31 | $9,534 |
| 2023-12-31 | $8,571 |
| 2023-09-30 | $8,386 |
| 2023-06-30 | $8,494 |
| 2023-03-31 | $8,495 |
| 2022-12-31 | $8,915 |
| 2022-09-30 | $8,564 |
| 2022-06-30 | $8,802 |
| 2022-03-31 | $9,067 |
| 2021-12-31 | $8,804 |
| 2021-09-30 | $8,824 |
| 2021-06-30 | $8,847 |
| 2021-03-31 | $9,082 |
| 2020-12-31 | $9,130 |
| 2020-09-30 | $9,325 |
| 2020-06-30 | $9,278 |
| 2020-03-31 | $9,331 |
| 2019-12-31 | $8,592 |
| 2019-09-30 | $9,590 |
| 2019-06-30 | $7,591 |
| 2019-03-31 | $7,590 |
| 2018-12-31 | $4,803 |
| 2018-09-30 | $4,806 |
| 2018-06-30 | $4,808 |
| 2018-03-31 | $4,803 |
| 2017-12-31 | $3,815 |
| 2017-09-30 | $4,416 |
| 2017-06-30 | $4,817 |
| 2017-03-31 | $5,509 |
| 2016-12-31 | $5,420 |
| 2016-09-30 | $5,171 |
| 2016-06-30 | $5,173 |
| 2016-03-31 | $5,424 |
| 2015-12-31 | $5,674 |
| 2015-09-30 | $5,796 |
| 2015-06-30 | $5,069 |
| 2015-03-31 | $3,845 |
| 2014-12-31 | $3,841 |
| 2014-09-30 | $4,249 |
| 2014-06-30 | $4,252 |
| 2014-03-31 | $4,245 |
| 2013-12-31 | $4,237 |
| 2013-09-30 | $4,246 |
| 2013-06-30 | $3,647 |
| 2013-03-31 | $4,250 |
| 2012-12-31 | $4,252 |
| 2012-09-30 | $4,252 |
| 2012-06-30 | $4,253 |
| 2012-03-31 | $4,255 |
| 2011-12-31 | $4,257 |
| 2011-09-30 | $4,259 |
| 2011-06-30 | $4,197 |
| 2011-03-31 | $4,670 |
| 2010-12-31 | $4,934 |
| 2010-09-30 | $5,133 |
| 2010-06-30 | $5,183 |
| 2010-03-31 | $5,671 |
| 2009-12-31 | $5,915 |
| 2009-09-30 | $5,774 |
| 2009-06-30 | $5,920 |
| 2009-03-31 | $6,242 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $147.057B | $16.747B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.365B | 28.30 |
| Stryker (SYK) | United States | $145.454B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $130.907B | 0.00 |
| Medtronic (MDT) | Ireland | $112.941B | 16.01 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.659B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.106B | 27.97 |
| ResMed (RMD) | United States | $36.856B | 27.68 |
| Agilent Technologies (A) | United States | $34.008B | 22.17 |
| GE HealthCare Technologies (GEHC) | United States | $33.609B | 15.96 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.270B | 83.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.645B | 11.98 |
| Baxter (BAX) | United States | $16.114B | 12.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.196B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.264B | 21.80 |
| Lantheus Holdings (LNTH) | United States | $5.587B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.206B | 18.79 |
| Perrigo (PRGO) | Ireland | $3.763B | 9.54 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.435B | 15.65 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Envista Holdings (NVST) | United States | $3.259B | 27.08 |
| GN Store Nord (GNNDY) | Denmark | $2.362B | 19.57 |
| QuidelOrtho (QDEL) | United States | $2.094B | 14.40 |
| LeMaitre Vascular (LMAT) | United States | $1.878B | 41.99 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| Neogen (NEOG) | United States | $1.238B | 15.85 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| BioLife Solutions (BLFS) | United States | $1.128B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.075B | 24.19 |
| Kestra Medical Technologies (KMTS) | United States | $1.001B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.989B | 12.64 |
| InMode (INMD) | Israel | $0.903B | 9.10 |
| Evolus (EOLS) | United States | $0.660B | 0.00 |
| CeriBell (CBLL) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.606B | 5.03 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.340B | 60.40 |
| Canopy Growth (CGC) | Canada | $0.289B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| ZimVie (ZIMV) | United States | $0.265B | 12.06 |
| Cresco Labs (CRLBF) | United States | $0.261B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| OraSure Technologies (OSUR) | United States | $0.218B | 0.00 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.09 |
| Verano Holdings (VRNOF) | United States | $0.183B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 16.05 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.61 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.21 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |